Hardman Gillian, Sutcliffe Ruth, Hogg Rachel, Mumford Lisa, Grocott Laura, Jerrett Lorraine, Mead-Regan Sarah-Jane, Nuttall Jane, Dunn Stephanie, Seeley Philip, Quigley Richard, Dalzell Johnathan R, Al-Attar Nawwar, Parameshwar Jayan, Fisher Andrew J, Booth Karen, Dark John H
Clinical Research and Clinical Audit Fellow in Cardiothoracic Transplantation, NHS Blood and Transplant, Bristol, UK.
Institute of Transplantation, Freeman Hospital, Newcastle upon Tyne, UK.
Clin Transplant. 2021 May;35(5):e14261. doi: 10.1111/ctr.14261. Epub 2021 Mar 9.
We aim to evaluate practice and understand the impact of the first wave of the SARS-CoV-2 pandemic on heart transplantation in the UK.
A retrospective review of the UK Transplant Registry (UKTR) and a national survey of UK heart transplant centers have been performed. The early pandemic period is defined here as 1 March to 31 May 2020.
There was geographic variation in the prevalence of COVID-19 across the UK. All centers reported adaptations to maintain the safety of their staff, candidate, and recipient populations. The number of donors fell by 31% during the early pandemic period. Heart utilization increased to 35%, compared to 26% during the same period of 2019. The number of heart transplants was well maintained, across all centers, with 38 performed, compared to 41 during the same period of 2019, with no change in 30-day survival. Twenty-seven heart transplant recipients with confirmed COVID-19 infection were reported during the study period.
All UK heart transplant centers have successfully adapted their programs to overcome the challenges of staff redeployment and ICU and hospital resource limitation, associated with the pandemic, whilst continuing heart transplant activity. On-going evaluation of practice changes, with sharing of lessons learned, is required as the pandemic continues.
我们旨在评估实际情况,并了解严重急性呼吸综合征冠状病毒2(SARS-CoV-2)大流行的第一波对英国心脏移植的影响。
对英国移植登记处(UKTR)进行了回顾性审查,并对英国心脏移植中心进行了全国性调查。此处将大流行早期定义为2020年3月1日至5月31日。
英国各地2019冠状病毒病(COVID-19)的流行情况存在地域差异。所有中心都报告了为维护工作人员、候选人和受者群体的安全而做出的调整。在大流行早期,捐赠者数量下降了31%。心脏利用率增至35%,而2019年同期为26%。所有中心的心脏移植数量都得到了良好维持,共进行了38例,而2019年同期为41例,30天生存率没有变化。在研究期间,报告了27例确诊感染COVID-19的心脏移植受者。
英国所有心脏移植中心都成功调整了其项目,以克服与大流行相关的人员调配以及重症监护病房(ICU)和医院资源限制等挑战,同时继续开展心脏移植活动。随着大流行的持续,需要对实践变化进行持续评估,并分享经验教训。